BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6153725)

  • 1. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
    Skinner DG; Scardino PT
    J Urol; 1980 Mar; 123(3):378-82. PubMed ID: 6153725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
    Skinner DG; Scardino PT
    Trans Am Assoc Genitourin Surg; 1979; 71():31-5. PubMed ID: 94715
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
    Fowler JE; Taylor G; Blom J; Stutzman RE
    J Urol; 1980 Sep; 124(3):365-8. PubMed ID: 6159485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
    Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
    J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
    Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L; Pilotti S
    J Urol; 1987 Dec; 138(6):1393-6. PubMed ID: 2824862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical Stage II nonseminomatous germinal testis tumors.
    Pizzocaro G; Zanoni F; Milani A; Piva L; Salvioni R; Pasi M; Pilotti S; Monfardini S
    Cancer; 1984 Mar; 53(6):1363-8. PubMed ID: 6198070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 9. Germ-cell tumors of the testis: improved results in a prospective study using combined modality therapy and biochemical tumor markers.
    Scardino PT; Skinner DG
    Surgery; 1979 Jul; 86(1):86-93. PubMed ID: 88077
    [No Abstract]   [Full Text] [Related]  

  • 10. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
    Otto T; Goepel M; Seeber S; Rübben H
    Urologe A; 1993 May; 32(3):189-93. PubMed ID: 7685554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy in non-seminomatous testis cancer: "mini-VAB" regimen: long-term followup.
    Vugrin D; Whitmore WF; Cvitkovic E; Golbey RB
    J Urol; 1981 Jul; 126(1):49-51. PubMed ID: 6166760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of tumor marker positivity in germinal non-seminomatous tumors of the testis].
    Bassetto MA; Franceschi T; Lenotti M; Pancheri F; Zaninelli M; Corgnati A; Cetto GL
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):89-90. PubMed ID: 1709212
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-seminomatous germ cell tumors of the testis. Analysis of AFP and HCG production by primary tumors and retroperitoneal lymph node metastases after PVB combination chemotherapy.
    Suurmeijer AJ; Oosterhuis JW; Marrink J; De Bruin HW; Schraffordt Koops H; Sleijfer DT; Fleuren GJ
    Oncodev Biol Med; 1983; 4(4):289-308. PubMed ID: 6188132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical analysis of management of pediatric testicular germ cell tumors.
    Ye YL; Sun XZ; Zheng FF; Bian J; Huang YP; Zhang XQ; Li ZX; Nie Y; Qin ZK; Dai YP
    Urology; 2012 Apr; 79(4):892-7. PubMed ID: 22305424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
    Nørgaard-Pedersen B; Schultz HP; Arends J; Brincker H; Krag Jacobsen G; Lindeløv B; Rørth M; Svennekjaer IL
    Acta Radiol Oncol; 1984; 23(4):287-94. PubMed ID: 6208749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA).
    Klepp O; Flodgren P; Maartman-Moe H; Lindholm CE; Unsgaard B; Teigum H; Fosså SD; Paus E
    Ann Oncol; 1990 Jul; 1(4):281-8. PubMed ID: 1702312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.
    Logothetis CJ; Swanson DA; Dexeus F; Chong C; Ogden S; Ayala AG; von Eschenbach AC; Johnson DE; Samuels ML
    J Clin Oncol; 1987 Jun; 5(6):906-11. PubMed ID: 2438389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
    Fottner C; Sattarova S; Hoffmann K; Spöttl G; Weber MM
    Eur J Endocrinol; 2008 Sep; 159(3):317-27. PubMed ID: 18524796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.